In fact, the effectiveness of 5-LOX/sEH dual inhibitionapproach has also been confirmed in vivo when compound 73 was challenged in two different murine models: zymosan-inducedperitonitis and ovalbumin-induced asthma. This evidence concerns the gene ALOX5 and asthma.